Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sigilon Therapeutics (SGTX)
NASDAQ:SGTX
Sigilon Therapeutics (SGTX) Stock Price & Analysis
84 Followers
SGTX Stock Chart & Stats
Day’s Range$22.09 - $23.1
52-Week Range― - ―
Previous Close$23.06
Volume83.68K
Average Volume (3M)N/A
Market Cap
$56.50M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$21.00Price Target Upside-6.54% Downside
Rating ConsensusHold
Number of Analyst Covering2
Sigilon Therapeutics News
PremiumPress Releases
Lilly to Acquire Sigilon TherapeuticsRisk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SGTX FAQ
What was Sigilon Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Sigilon Therapeutics’s market cap?
Currently, no data Available
When is Sigilon Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sigilon Therapeutics’s earnings last quarter?
Currently, no data Available
Is Sigilon Therapeutics overvalued?
According to Wall Street analysts Sigilon Therapeutics’s price is currently Overvalued.
Does Sigilon Therapeutics pay dividends?
Sigilon Therapeutics does not currently pay dividends.
What is Sigilon Therapeutics’s EPS estimate?
Sigilon Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sigilon Therapeutics have?
Currently, no data Available
What happened to Sigilon Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sigilon Therapeutics?
Among the largest hedge funds holding Sigilon Therapeutics’s share is Flagship Pioneering Inc.. It holds Sigilon Therapeutics’s shares valued at 9M.
---
Sigilon Therapeutics Stock Smart Score
Company Description
Sigilon Therapeutics
Sigilon Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is developing a new class of therapeutics and functional cures for patients with chronic diseases by providing stable and durable levels of therapeutic molecules to patients.
---
SGTX Stock 12 Months Forecast
Average Price Target
$21.00
▼(-6.54% Downside)
BioMarin Pharmaceutical
―
Neurocrine
―
Nektar Therapeutics
―
Ultragenyx Pharmaceutical
―
Best Analysts Covering SGTX
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+214.70%
initiated a buy rating a year ago
Copying Whitney Ijem's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +214.70% per trade.
---